Longport LPTI · USD

Market value

$2,308

Last close × shares

Volume

27k

Shares, 30 Oct 2026

Its shares trade under the ticker LPTI. It has been listed since 7 September 1994. In the fiscal year to 31 December 2004, it reported revenue of $2.5m and a net loss of $633,532. At that date it held total assets of $2.7m and shareholders' equity of $903,873.

Longport, Inc. engages in the manufacture, development, marketing, and sale of high resolution ultrasound imaging systems. The company is headquartered in Chadds Ford, Pennsylvania. The firm focuses on high resolution medical ultrasound. The firm focuses on providing imaging systems that help in the prevention, assessment and treatment of medical conditions. The firm offers a high resolution ultrasound (HRUS) imaging system, EPISCAN I-200, which utilizes ultrasound to image the skin and underlying soft tissue. EPISCAN I-200 can be connected to a range of interchangeable imaging probes that enable the imaging of the skin and underlying soft tissue at frequencies between 20 megahertz and 50 megahertz. EPISCAN is utilized in a range of clinical applications, as well as in research and development. EPISCAN enables the examination of tissue at a microscopic level. Its technology is used in a range of applications, such as wound assessment and pressure ulcer prevention, dermatology, aesthetics, and research, including validation of processes and products that impact the skin.

Figures and description from our data supplier, not checked against the company's own report.

More about Longport →

We have not reported on Longport yet.

Leaves out fees, taxes and financing.

Chart

TradingView

Close and company data

Our data supplier

News

Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.